Patients with Depression or Anxiety Are Losing Sleep

Published Online: Saturday, April 1, 2006

According to an article reported in General Hospital Psychiatry (March-April 2005), patients with insomnia may be dealing with more than lost sleep. Chronic insomnia may in fact be a marker for a psychiatric disorder, particularly depression or anxiety. At least 40% of patients with chronic insomnia also have an underlying psychiatric disorder. Comorbid insomnia in patients with major depressive episodes often is manifested by difficulty in maintaining sleep. With generalized anxiety disorder, a patient's sleep is often shortened and fragmented. Unfortunately, the medications used to treat depression or anxiety actually may exacerbate the patient's inability to sleep soundly.

When insomnia and a psychiatric disorder coexist, it often is difficult to know which came first. Whereas a psychiatric disorder may cause insomnia, insomnia may be a factor in developing a psychiatric disorder. A history of insomnia is associated with a 4-fold increase in the risk of developing a new depressive disorder and a 2-fold increase in the risk of developing a new anxiety disorder. In fact, emerging data suggest that resolution of insomnia may improve psychiatric outcomes—underscoring the importance of a vigorous approach to treating insomnia. Because of the impact on insomnia of many medications for psychiatric conditions, an ideal approach would be a monotherapy that treats both insomnia and the psychiatric disorder.

Latest Articles
James Schiffer, RPh, associate at Allegaert Berger & Vogel LLC, discusses some tips for pharmacists who are facing a Drug Enforcement Administration audit.
Carlos Aquino, founder and president of PharmaDiversion LLC, talks about the importance of the Drug Enforcement Administration's (DEA) diversion website.
Having trouble getting your hands on FluMist?
Novartis is paying $390 million to settle charges that it paid kickbacks to pharmacies to encourage drug sales.
Latest Issues